Literature DB >> 22539171

Leg intramuscular pressures and in vivo knee forces during lower body positive and negative pressure treadmill exercise.

Brandon R Macias1, Darryl D D'Lima, Adnan Cutuk, Shantanu Patil, Nick Steklov, Timothy B Neuschwander, Sabine Meuche, Clifford W Colwell, Alan R Hargens.   

Abstract

Quantifying muscle and joint forces over a broad range of weight bearing loads during exercise may provide data required to improve prosthetic materials and better protect against muscle and bone loss. Collectively, leg intramuscular pressure (IMP), ground reaction force (GRF), and the instrumented tibial tray force measurements provide a comprehensive assessment of leg muscle and joint biomechanical effects of gravity during exercise. Titration of body weight (BW) by lower body negative pressure (LBNP) and lower body positive pressure (LBPP) can reproducibly modulate IMP within leg muscle compartments. In addition, previous studies document peak tibial forces during various daily activities of 2.2 to 2.5 BW. The study objective was to determine the IMPs of the leg, axial compressive force on the tibia in vivo, vertical GRF, and knee range of motion during altered BW levels using LBPP and LBNP treadmill exercise. We hypothesize that peak GRF, peak tibial forces, and peak IMPs of the leg correlate linearly with percent BW, as generated across a broad range of upright LBPP and supine LBNP exercise. When running at 2.24 m/s the leg IMPs significantly increased over the loading range of 60% to 140% BW with LBPP and LBNP (P < 0.001); as expected, leg IMPs were significantly higher when running compared with standing (P < 0.001). During upright LBPP, total axial force at the knee increased linearly as a function of BW at 0.67 m/s (R(2) = 0.90) and 1.34 m/s (R(2) = 0.98). During supine LBNP, total axial force at the knee increased linearly as a function of BW at 0.67 m/s (R(2) = 0.98) and 1.34 m/s (R(2) = 0.91). The present study is the first to measure IMPs and peak tibial forces in vivo during upright LBPP, upright LBNP, and supine LBNP exercise. These data will aid the development of rehabilitation exercise hardware and prescriptions for patients and astronauts.

Entities:  

Mesh:

Year:  2012        PMID: 22539171     DOI: 10.1152/japplphysiol.01434.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  6 in total

1.  Comparison of cardiovascular and biomechanical parameters of supine lower body negative pressure and upright lower body positive pressure to simulate activity in 1/6 G and 3/8 G.

Authors:  Thomas Schlabs; Armando Rosales-Velderrain; Heidi Ruckstuhl; Alexander C Stahn; Alan R Hargens
Journal:  J Appl Physiol (1985)       Date:  2013-05-02

2.  CLINICAL DECISION MAKING AND TREATMENT IN A RUNNER WITH HIP PAIN AND NEUROMUSCULAR CONTROL DYSFUNCTION: A CASE REPORT.

Authors:  C Nathan Vannatta; Matthew Haberl
Journal:  Int J Sports Phys Ther       Date:  2018-04

3.  Physiological Responses During the Lower Body Positive Pressure Supported Treadmill Test.

Authors:  Ka-Young Lee; Jae-Young Han; Ji-Hyun Kim; Dong-Ju Kim; In-Sung Choi
Journal:  Ann Rehabil Med       Date:  2016-10-31

4.  Lower-body positive pressure diminishes surface blood flow reactivity during treadmill walking.

Authors:  Junichi Tajino; Akira Ito; Yusuke Torii; Koji Tsuchimoto; Hirotaka Iijima; Xiangkai Zhang; Momoko Tanima; Shoki Yamaguchi; Hiroshi Ieki; Ryosuke Kakinoki; Hiroshi Kuroki
Journal:  BMC Res Notes       Date:  2019-11-08

Review 5.  Implantable sensor technology: measuring bone and joint biomechanics of daily life in vivo.

Authors:  Darryl D D'Lima; Benjamin J Fregly; Clifford W Colwell
Journal:  Arthritis Res Ther       Date:  2013-01-31       Impact factor: 5.156

6.  Treadmill exercise within lower-body negative pressure attenuates simulated spaceflight-induced reductions of balance abilities in men but not women.

Authors:  Timothy R Macaulay; Brandon R Macias; Stuart Mc Lee; Wanda L Boda; Donald E Watenpaugh; Alan R Hargens
Journal:  NPJ Microgravity       Date:  2016-06-30       Impact factor: 4.415

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.